A BioMADE-funded project demonstrated programmed cell-wall lysis at pilot scale, reducing the mechanical energy required for separation by more than 50% in one yeast strain.

South Korean CDMO raises 2026 revenue guidance, as Seoul High Court extends its injunction to nine production processes at Songdo site — just days before planned strike.

The company is tapping artificial intelligence and advanced analytics to build a “cognitive CDMO” connecting scientific knowledge with operational data.

The facilities in France and Singapore were recognized for their modular, scalable, AI-enabled design, producing multiple vaccine platforms and biologics simultaneously.

Wolfgang Wienand said this week that the company is focused on its overall breadth of capabilities, serving customers across scales, regions, and the entire lifecycle.

As part of its Capital Markets Day, the company hosted analysts at the California facility which it says is well-positioned for large-scale mammalian demand.

The CDMO’s 27,000-square-foot facility on the University of Minnesota’s St. Paul campus enables it to run multiple large-scale projects simultaneously.

Overseas markets take on increased attractiveness for India following President Trump’s threatened tariffs on generic drugs in 2028, finds data and analytics firm.